PATHOGENESIS, ETIOLOGY, TREATMENT, AND PREVENTION OF ATHEROSCLEROSIS IN ISCHEMIC HEART DISEASE

Authors

  • Nuriddinov Umed Zayniddin ugli Asia International University,Bukhara,Uzbekistan

DOI:

https://doi.org/10.55640/

Abstract

Ischemic Heart Disease (IHD) remains a leading cause of death and disability worldwide, largely due to atherosclerosis—a persistent inflammatory condition affecting arterial walls, driven by abnormal lipid metabolism and endothelial injury. This article examines the etiological factors of atherosclerosis, describes the stepwise cellular and molecular mechanisms of plaque development, and reviews contemporary therapeutic and preventive strategies aimed at slowing or halting coronary artery disease progression.

Downloads

Download data is not yet available.

References

1.Libby P. Inflammation in vascular disease. Nature Reviews Cardiology, 2021.

Lusis AJ. Atherosclerosis. Nature, 2000.

Fuster V, Gotto AM. Vulnerable plaques in atherosclerosis. American Heart Association Journals, 2019.

Yusuf S et al. Modifiable risk factors and cardiovascular outcomes. The Lancet, 2020.

2.Heusch, G. (2020). Myocardial Ischemia: Lack of Coronary Blood Flow or Myocardial Oxygen Deficiency? Circulation Research, 126(10), 1406–1420.

Downloads

Published

2026-01-19

How to Cite

PATHOGENESIS, ETIOLOGY, TREATMENT, AND PREVENTION OF ATHEROSCLEROSIS IN ISCHEMIC HEART DISEASE. (2026). Journal of Multidisciplinary Sciences and Innovations, 5(01), 1221-1222. https://doi.org/10.55640/